AKT1 and ovarian carcinoma: It has been reported that miR-484-5p is decreased in ovarian cancer tissues and cell lines, and its ectopic expression decreases cell proliferation in vitro and in vivo via targeting the SRC/p-PI3K/p-AKT pathway (Yang et al., 2020[147]).